Literature DB >> 1488065

Flavivirus induces MHC antigen on human myoblasts: a model of autoimmune myositis?

S Bao1, N J King, C G Dos Remedios.   

Abstract

Infection of human embryonic myoblasts by West Nile virus (WNV), a flavivirus, caused significant upregulation of class I and II MHC expression as determined by flow cytometry. After 48 hours at a multiplicity of infection of 5 pfu/cell, a sixfold increase in MHC class I expression was induced from initially low levels of expression. In contrast, MHC class II was induced de novo to five times the control fluorescence level. At least 70% of the cells were infected as determined using fluorescence microscopy and anti-WNV antibody labeling. Myoblasts were > 90% pure as shown by anti--Leu-19 labeling. MHC class I (but not class II) was increased threefold after exposure to virus-inactivated supernatant from 48-hour--infected cells, indicating the presence of factor(s) contributing to the MHC class I increase. These findings may be important in establishing a link between viral infection of human cells and induction of inflammatory autoimmune disease. We discuss the possibility of using WNV as an in vivo model.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1488065      PMCID: PMC7168366          DOI: 10.1002/mus.880151109

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  40 in total

1.  CIRCULATING ANTIBODIES IN POLYMYOSITIS AND OTHER MUSCLE-WASTING DISORDERS.

Authors:  E A CASPARY; S S GUBBAY; G M STERN
Journal:  Lancet       Date:  1964-10-31       Impact factor: 79.321

2.  Lymphocyte antigen Leu-19 as a molecular marker of regeneration in human skeletal muscle.

Authors:  W Schubert; K Zimmermann; M Cramer; A Starzinski-Powitz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 3.  Class II transplantation antigens: distribution in tissues and involvement in disease.

Authors:  U Forsum; K Claesson; E Hjelm; A Karlsson-Parra; L Klareskog; A Scheynius; U Tjernlund
Journal:  Scand J Immunol       Date:  1985-05       Impact factor: 3.487

4.  HLA-D related (DR) antigens in various kinds of myositis.

Authors:  T J Hirsch; R W Enlow; W B Bias; F C Arnett
Journal:  Hum Immunol       Date:  1981-10       Impact factor: 2.850

5.  Acute fulminant myoglobinuric polymyositis with picornavirus-like crystals.

Authors:  Y Fukuyama; T Ando; J Yokota
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-08       Impact factor: 10.154

6.  Viral particles induce Ia antigen expression on astrocytes.

Authors:  P T Massa; R Dörries; V ter Meulen
Journal:  Nature       Date:  1986 Apr 10-16       Impact factor: 49.962

7.  Elevated MHC class I and II antigens in cultured human embryonic myoblasts following stimulation with gamma-interferon.

Authors:  S S Bao; N J King; C G dos Remedios
Journal:  Immunol Cell Biol       Date:  1990-08       Impact factor: 5.126

Review 8.  Neuromuscular diseases associated with human immunodeficiency virus infection.

Authors:  M C Dalakas; G H Pezeshkpour
Journal:  Ann Neurol       Date:  1988       Impact factor: 10.422

9.  Induction of glial cell MHC antigen expression in neurotropic coronavirus infections. Characterization of the H-2-inducing soluble factor elaborated by infected brain cells.

Authors:  A Suzumura; E Lavi; S Bhat; D Murasko; S R Weiss; D H Silberberg
Journal:  J Immunol       Date:  1988-03-15       Impact factor: 5.422

10.  Differential modulation of MHC class I antigen expression on mouse brain endothelial cells by MHV-4 infection.

Authors:  J Joseph; R L Knobler; F D Lublin; M N Hart
Journal:  J Neuroimmunol       Date:  1989-05       Impact factor: 3.478

View more
  14 in total

1.  Transfection of single-stranded hepatitis A virus RNA activates MHC class I pathway.

Authors:  K Suzuki; M Yanagi; A Mori-Aoki; E Moriyama; K J Ishii; L D Kohn
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

2.  Professor Cristobal G dos Remedios mentorship.

Authors:  Shisan Bob Bao
Journal:  Biophys Rev       Date:  2020-07-13

3.  Early E-selectin, VCAM-1, ICAM-1, and late major histocompatibility complex antigen induction on human endothelial cells by flavivirus and comodulation of adhesion molecule expression by immune cytokines.

Authors:  J Shen; S S T-To; L Schrieber; N J King
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Adherence status regulates the primary cellular activation responses to the flavivirus West Nile.

Authors:  J Shen; J M Devery; N J King
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

5.  CTL recognition of west Nile virus-infected fibroblasts is cell cycle dependent and is associated with virus-induced increases in class I MHC antigen expression.

Authors:  M W Douglas; A M Kesson; N J King
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

6.  Antigen processing and presentation by a murine myoblast cell line.

Authors:  M J Garlepp; W Chen; H Tabarias; M Baines; A Brooks; J McCluskey
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

7.  Neuromuscular Manifestations of Human West Nile Virus Infection.

Authors:  A Arturo Leis; Dobrivoje S Stokic
Journal:  Curr Treat Options Neurol       Date:  2005-01       Impact factor: 3.972

8.  Inclusion body myositis: laser microdissection reveals differential up-regulation of IFN-γ signaling cascade in attacked versus nonattacked myofibers.

Authors:  Jana Ivanidze; Reinhard Hoffmann; Hanns Lochmüller; Andrew G Engel; Reinhard Hohlfeld; Klaus Dornmair
Journal:  Am J Pathol       Date:  2011-09       Impact factor: 4.307

9.  Neuromuscular manifestations of west nile virus infection.

Authors:  A Arturo Leis; Dobrivoje S Stokic
Journal:  Front Neurol       Date:  2012-03-21       Impact factor: 4.003

Review 10.  Antiviral macrophage responses in flavivirus encephalitis.

Authors:  Thomas Myles Ashhurst; Caryn van Vreden; Luis Munoz-Erazo; Paula Niewold; Kanami Watabe; Rachael L Terry; Celine Deffrasnes; Daniel R Getts; Nicholas Jonathan Cole King
Journal:  Indian J Med Res       Date:  2013-11       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.